Related Experiment Video
Updated: Mar 3, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Pulmonary dysfunction in 114 patients with inflammatory bowel disease
Yujie Zhao1, Junshan Wang, Zhanju Liu
1Department of Gastroenterology, Shanghai Tenth People's Hospital, Tongji University, Shanghai, China.
Inflammatory bowel disease (IBD) patients often exhibit decreased pulmonary function, characterized by restrictive or obstructive patterns. Early pulmonary function testing is recommended, especially for those with elevated erythrocyte sedimentation rate (ESR) or respiratory symptoms.
Area of Science:
- Gastroenterology and Pulmonology
- Clinical Medicine
Background:
- Inflammatory Bowel Disease (IBD) encompasses chronic conditions like ulcerative colitis and Crohn's disease.
- Pulmonary complications in IBD are increasingly recognized but often subclinical.
- Understanding pulmonary function in IBD is crucial for comprehensive patient management.
Purpose of the Study:
- To investigate pulmonary function abnormalities in patients with IBD.
- To identify clinical features and risk factors associated with pulmonary dysfunction in IBD.
Main Methods:
- A comparative study involving 114 IBD patients and 120 healthy controls.
- Comprehensive assessment of medical history, biochemical markers, and pulmonary function tests.
- Statistical analysis to compare IBD patients with controls and identify correlations.
Main Results:
- IBD patients showed significantly increased pulmonary ventilation, residual volume, and diffusion capacity (P < .05).
- Vital capacity, FVC, MVV, FEV1, PEFR, and MMEF were significantly decreased in IBD patients (P < .01).
- Erythrocyte sedimentation rate (ESR) was identified as a risk factor for pulmonary dysfunction.
Conclusions:
- Pulmonary function is significantly impaired in IBD patients, presenting as restrictive, obstructive, or mixed patterns.
- Pulmonary function did not correlate with IBD severity or extent.
- Pulmonary function testing in IBD patients, particularly those with high ESR or respiratory symptoms, is advisable to prevent severe lung damage.
More Related Videos
06:29Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo
Published on: May 5, 2023
09:00Characterization of Immune Cells and Proinflammatory Mediators in the Pulmonary Environment
Published on: June 24, 2020
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...